{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T03:47:19Z","timestamp":1776570439498,"version":"3.51.2"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100016692","name":"Key Research and Development Program of Ningxia","doi-asserted-by":"publisher","award":["2025BEG01003"],"award-info":[{"award-number":["2025BEG01003"]}],"id":[{"id":"10.13039\/100016692","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81860538"],"award-info":[{"award-number":["81860538"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31860328"],"award-info":[{"award-number":["31860328"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.bbrc.2026.153708","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T06:42:50Z","timestamp":1774939370000},"page":"153708","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["RNF146 enhances olaparib sensitivity in triple-negative breast cancer via XRCC5 downregulation"],"prefix":"10.1016","volume":"816","author":[{"given":"Meng","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yezhen","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongning","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huihui","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhijun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2026.153708_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16061139","article-title":"Triple-negative breast cancer and emerging therapeutic strategies: ATR and CHK1\/2 as promising targets","volume":"16","author":"Sofianidi","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.bbrc.2026.153708_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14051253","article-title":"Triple negative breast cancer: updates on classification and treatment in 2021","volume":"14","author":"Bou Zerdan","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.bbrc.2026.153708_bib3","doi-asserted-by":"crossref","DOI":"10.1177\/15330338221145246","article-title":"Molecular classification, treatment, and genetic biomarkers in triple-negative breast cancer: a review","volume":"22","author":"Lu","year":"2023","journal-title":"Technol. Cancer Res. Treat."},{"key":"10.1016\/j.bbrc.2026.153708_bib4","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/his.14784","article-title":"Update on triple\u2010negative breast cancers \u2013 highlighting subtyping update and treatment implication","volume":"82","author":"Tsang","year":"2022","journal-title":"Histopathology"},{"key":"10.1016\/j.bbrc.2026.153708_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/medicina57010062","article-title":"Triple negative breast cancer: a review of present and future diagnostic modalities","volume":"57","author":"Dass","year":"2021","journal-title":"Medicina"},{"key":"10.1016\/j.bbrc.2026.153708_bib6","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqac172","article-title":"Estrogen receptor beta 1: a potential therapeutic target for female triple negative breast cancer","volume":"163","author":"Dey","year":"2022","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbrc.2026.153708_bib7","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.currproblcancer.2016.09.004","article-title":"Targeting the androgen receptor in triple-negative breast cancer","volume":"40","author":"Gucalp","year":"2016","journal-title":"Curr. Probl. Cancer"},{"key":"10.1016\/j.bbrc.2026.153708_bib8","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/s12276-021-00557-3","article-title":"Alternate therapeutic pathways for PARP inhibitors and potential mechanisms of resistance","volume":"53","author":"Kim","year":"2021","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.bbrc.2026.153708_bib9","first-page":"1","article-title":"The profile and clinical evidence of effectiveness of olaparib in triple-negative breast cancer: a review","volume":"4","author":"Faathiansyah","year":"2024","journal-title":"Int. J. Soc. Serv. Res."},{"key":"10.1016\/j.bbrc.2026.153708_bib10","doi-asserted-by":"crossref","first-page":"6001","DOI":"10.2147\/IJN.S426639","article-title":"A progressively disassembled DNA repair inhibitors nanosystem for the treatment of BRCA wild-type triple-negative breast cancer","volume":"18","author":"Fang","year":"2023","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.bbrc.2026.153708_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2025.101034","article-title":"Multi-omics characterization of acquired olaparib resistance in BRCA1 and BRCA2 mutant breast cancer cell lines","volume":"24","author":"Anagho-Mattanovich","year":"2025","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.bbrc.2026.153708_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-021-00648-7","article-title":"DNA damage repair: historical perspectives, mechanistic pathways and clinical translation for targeted cancer therapy","volume":"6","author":"Huang","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.bbrc.2026.153708_bib13","article-title":"Targeting the DNA damage response for cancer therapy","volume":"24","author":"Wang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2026.153708_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232314672","article-title":"DNA damage response in cancer therapy and resistance: challenges and opportunities","volume":"23","author":"Jurkovicova","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2026.153708_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24032760","article-title":"DNA damage response mechanisms in head and neck cancer: significant implications for therapy and survival","volume":"24","author":"Papalouka","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2026.153708_bib16","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2023.5296","article-title":"Advances in the role of long non-coding RNAs and RNA-binding proteins in regulating DNA damage repair in cancer cells","volume":"52","author":"Zou","year":"2023","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.bbrc.2026.153708_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/biom15020237","article-title":"Targeting the PARylation-Dependent ubiquitination signaling pathway for cancer therapies","volume":"15","author":"Huang","year":"2025","journal-title":"Biomolecules"},{"key":"10.1016\/j.bbrc.2026.153708_bib18","first-page":"4383","article-title":"SUMOylation of RNF146 results in axin degradation and activation of Wnt\/\u03b2-catenin signaling to promote the progression of hepatocellular carcinoma","volume":"42","author":"Yin","year":"2023","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2026.153708_bib19","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/nature13826","article-title":"Allosteric activation of the RNF146 ubiquitin ligase by a poly(ADP-ribosyl)ation signal","volume":"517","author":"DaRosa","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2026.153708_bib20","doi-asserted-by":"crossref","first-page":"463","DOI":"10.4161\/cam.5.6.18356","article-title":"Ring finger protein 146\/Iduna is a Poly(ADP-ribose) polymer binding and PARsylation dependent E3 ubiquitin ligase","volume":"5","author":"Zhou","year":"2014","journal-title":"Cell Adhes. Migrat."},{"key":"10.1016\/j.bbrc.2026.153708_bib21","doi-asserted-by":"crossref","first-page":"231","DOI":"10.21873\/cdp.10313","article-title":"Expression of DNA repair genes in ewing sarcoma","volume":"4","author":"Kyriazoglou","year":"2024","journal-title":"Cancer Diagn. Progn."},{"key":"10.1016\/j.bbrc.2026.153708_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-74138-5","article-title":"Negative feedback loop in the activation of non-homologous end joining DNA repair pathway in Helicobacter pylori infected patients with gastritis","volume":"14","author":"Amirnorouzi","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2026.153708_bib23","doi-asserted-by":"crossref","DOI":"10.1186\/s12929-022-00870-7","article-title":"Biomarkers beyond BRCA: promising combinatorial treatment strategies in overcoming resistance to PARP inhibitors","volume":"29","author":"Chu","year":"2022","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.bbrc.2026.153708_bib24","doi-asserted-by":"crossref","DOI":"10.1093\/narcan\/zcad043","article-title":"The dynamic process of covalent and non-covalent PARylation in the maintenance of genome integrity: a focus on PARP inhibitors","volume":"5","author":"Beneyton","year":"2023","journal-title":"NAR Cancer"},{"key":"10.1016\/j.bbrc.2026.153708_bib25","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s11912-025-01669-z","article-title":"PARP inhibitors in the neoadjuvant setting; A comprehensive overview of the rationale for their use, past and ongoing clinical trials","volume":"27","author":"Habaka","year":"2025","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.bbrc.2026.153708_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.893888","article-title":"HIF-1\/2\u03b1-Activated RNF146 enhances the proliferation and glycolysis of hepatocellular carcinoma cells via the PTEN\/AKT\/mTOR pathway","volume":"10","author":"Shen","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bbrc.2026.153708_bib27","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s10689-009-9255-7","article-title":"The RNF146 and ECHDC1 genes as candidates for inherited breast and ovarian cancer in Jewish Ashkenazi women","volume":"8","author":"Menachem","year":"2009","journal-title":"Fam. Cancer"},{"key":"10.1016\/j.bbrc.2026.153708_bib28","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/ncb2222","article-title":"RNF146 is a poly(ADP-ribose)-directed E3 ligase that regulates axin degradation and Wnt signalling","volume":"13","author":"Zhang","year":"2011","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbrc.2026.153708_bib29","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.788","article-title":"Targeting the DNA damage response in cancer","volume":"5","author":"Guffanti","year":"2024","journal-title":"MedComm"},{"key":"10.1016\/j.bbrc.2026.153708_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.943090","article-title":"A score of DNA damage repair pathway with the predictive ability for chemotherapy and immunotherapy is strongly associated with immune signaling pathway in pan-cancer","volume":"13","author":"Ding","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbrc.2026.153708_bib31","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkaf627","article-title":"A cancer persistent DNA repair circuit driven by MDM2, MDM4 (MDMX), and mutant p53 for recruitment of MDC1 and 53BP1 on chromatin","volume":"53","author":"Ellison","year":"2025","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbrc.2026.153708_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27154736","article-title":"Targeting replication stress response pathways to enhance genotoxic Chemo- and radiotherapy","volume":"27","author":"Nickoloff","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.bbrc.2026.153708_bib33","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.radonc.2021.03.038","article-title":"Impact of DNA repair and reactive oxygen species levels on radioresistance in pancreatic cancer","volume":"159","author":"Nguyen","year":"2021","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.bbrc.2026.153708_bib34","series-title":"Multiple E3 Ligases Control Tankyrase Stability and Function","author":"Perrard","year":"2023"},{"key":"10.1016\/j.bbrc.2026.153708_bib35","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1038\/nm.3739","article-title":"Ubiquitination in disease pathogenesis and treatment","volume":"20","author":"Popovic","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2026.153708_bib36","doi-asserted-by":"crossref","first-page":"3761","DOI":"10.1093\/nar\/gkae064","article-title":"NUDT16 regulates CtIP PARylation to dictate homologous recombination repair","volume":"52","author":"Zhang","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbrc.2026.153708_bib37","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1002\/ptr.8135","article-title":"Pimpinellin ameliorates macrophage inflammation by promoting RNF146\u2010mediated PARP1 ubiquitination","volume":"38","author":"Yang","year":"2024","journal-title":"Phytother Res."},{"key":"10.1016\/j.bbrc.2026.153708_bib38","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2122805119","article-title":"Tankyrases inhibit innate antiviral response by PARylating VISA\/MAVS and priming it for RNF146-mediated ubiquitination and degradation","volume":"119","author":"Xu","year":"2022","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbrc.2026.153708_bib39","doi-asserted-by":"crossref","DOI":"10.1186\/s13073-025-01488-8","article-title":"DNA repair and the contribution to chemotherapy resistance","volume":"17","author":"Nesic","year":"2025","journal-title":"Genome Med."},{"key":"10.1016\/j.bbrc.2026.153708_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/genes14071346","article-title":"Therapeutic targeting of DNA replication stress in cancer","volume":"14","author":"Gu","year":"2023","journal-title":"Genes"},{"key":"10.1016\/j.bbrc.2026.153708_bib41","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.220118","article-title":"Opinion: PARP inhibitors in cancer\u2014what do we still need to know?","volume":"12","author":"Wicks","year":"2022","journal-title":"Open Biol."},{"key":"10.1016\/j.bbrc.2026.153708_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/cells12141904","article-title":"Unravelling the role of PARP1 in homeostasis and tumorigenesis: implications for anti-cancer therapies and overcoming resistance","volume":"12","author":"Lovsund","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.bbrc.2026.153708_bib43","doi-asserted-by":"crossref","first-page":"4475","DOI":"10.1016\/j.cell.2023.08.030","article-title":"ADP-ribosylation from molecular mechanisms to therapeutic implications","volume":"186","author":"Suskiewicz","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2026.153708_bib44","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1042\/BST20220749","article-title":"The function and regulation of ADP-ribosylation in the DNA damage response","volume":"51","author":"Duma","year":"2023","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.bbrc.2026.153708_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.105397","article-title":"ADP-ribose contributions to genome stability and PARP enzyme trapping on sites of DNA damage; paradigm shifts for a coming-of-age modification","volume":"299","author":"Rouleau-Turcotte","year":"2023","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2026.153708_bib46","article-title":"Prospects for PARG inhibitors in cancer therapy","volume":"16","author":"Hu","year":"2024","journal-title":"J. Mol. Cell Biol."},{"key":"10.1016\/j.bbrc.2026.153708_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.105032","article-title":"PC4-mediated Ku complex PARylation facilitates NHEJ-dependent DNA damage repair","volume":"299","author":"Pan","year":"2023","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2026.153708_bib48","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201846166","article-title":"Poly(ADP\u2010ribosyl)ation of BRD7 by PARP1 confers resistance to DNA\u2010damaging chemotherapeutic agents","volume":"20","author":"Hu","year":"2019","journal-title":"EMBO Rep."},{"key":"10.1016\/j.bbrc.2026.153708_bib49","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1038\/s41467-025-56347-2","article-title":"Brd7 loss reawakens dormant metastasis initiating cells in lung by forging an immunosuppressive niche","volume":"16","author":"Mondal","year":"2025","journal-title":"Nat. Commun."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26004729?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26004729?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T03:31:22Z","timestamp":1776569482000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X26004729"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":49,"alternative-id":["S0006291X26004729"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.153708","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RNF146 enhances olaparib sensitivity in triple-negative breast cancer via XRCC5 downregulation","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.153708","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"153708"}}